Vir Biotechnology, Inc. VIR Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s enterprise value?
- Vir Biotechnology, Inc. (VIR) reported enterprise value of $1.24B in Q1 2026.
- How has Vir Biotechnology, Inc.'s enterprise value changed year-over-year?
- Vir Biotechnology, Inc.'s enterprise value increased by 101.8% year-over-year, from $616.79M to $1.24B.
- What is the long-term trend for Vir Biotechnology, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s enterprise value has grown at a -26.0% compound annual growth rate (CAGR), from $3.14B to $695.71M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.